Literature DB >> 15731067

Gastric helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase.

Melanie Ihrig1, Mark T Whary, Charles A Dangler, James G Fox.   

Abstract

Persistent Helicobacter felis infection in (C57BL/6 x 129SvEv)F1 mice induces chronic gastritis. Expression of inducible nitric oxide synthase (iNOS) is upregulated in response to Helicobacter infection. In this study, 20 10-week-old iNOS-/- mice and 20 wild-type [(C57BL/6 x 129SvEv)F1] mice were infected with H. felis by oral gavage and were assessed histologically and serologically at 32 weeks postinfection. Equal numbers of uninfected controls were sham inoculated. The mice were scored for severity of gastric inflammation, hyperplasia, glandular atrophy, and mucous metaplasia in the corpus and for the level of helicobacter colonization. The immunoglobulin G1 (IgG1), IgG2a, and IgG2c antibody responses to H. felis were determined. As a secondary measure, serum cholesterol levels were assessed. iNOS-/- mice have a propensity for increased serum cholesterol, and although controversial, several human epidemiologic studies have demonstrated an association between Helicobacter infection and several risk factors for cardiovascular disease, including elevated serum cholesterol. Nevertheless, no differences in serum cholesterol levels were observed between the H. felis-infected and -uninfected iNOS-/- mice in this study. The uninfected animals had minimal to no gastric pathology. The gastric pathology scores for the infected animals were reduced significantly in the iNOS-deficient mice relative to those for the wild-type mice (all P <0.01). Helicobacter-infected iNOS-/- mice had chronic lymphoid infiltration and negligible to mild glandular atrophy and mucous metaplasia in the fundic mucosa, while H. felis-infected wild-type mice had severe atrophic and metaplastic mucosal changes. The atrophic gastritis in the infected wild-type mice, particularly the female mice, was also accompanied by greater granulocytic infiltration, antral hyperplasia, and diminished antral colonization, unlike that in the infected iNOS-/- mice. iNOS-/- mice developed significantly lower Th1-associated IgG2c antibody responses to H. felis (P <0.0003); the Th2-associated IgG1 responses were similar (P=0.09), suggesting a greater effect of the iNOS defect on Th1 responses. H. felis colonization was significantly greater in the iNOS-deficient mice. These findings are indicative of an impaired Th1 component of the H. felis-induced inflammatory response when the influence of iNOS is removed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731067      PMCID: PMC1064950          DOI: 10.1128/IAI.73.3.1664-1670.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.

Authors:  H J Son; J C Rhee; D I Park; Y H Kim; P L Rhee; K C Koh; S W Paik; K W Choi; J J Kim
Journal:  Helicobacter       Date:  2001-03       Impact factor: 5.753

2.  Nitric oxide as a regulatory and effector molecule in the immune system.

Authors:  Vladimír Holán; Magdaléna Krulová; Alena Zajícová; Jana Pindjáková
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

3.  A Sp1 binding site of the tumor necrosis factor alpha promoter functions as a nitric oxide response element.

Authors:  S Wang; W Wang; R A Wesley; R L Danner
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

4.  Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas.

Authors:  M Ihrig; C A Dangler; J G Fox
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

Review 5.  Nitric oxide in immunity and inflammation.

Authors:  J W Coleman
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

Review 6.  Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival.

Authors:  K D Kröncke; K Fehsel; C Suschek; V Kolb-Bachofen
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

7.  Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection.

Authors:  Marygorret Obonyo; Donald G Guiney; Julia Harwood; Joshua Fierer; Sheri P Cole
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  Increased oxidative and nitrative stress in human stomach associated with cagA+ Helicobacter pylori infection and inflammation.

Authors:  C Q Li; B Pignatelli; H Ohshima
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

9.  Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses.

Authors:  James G Fox; Barbara J Sheppard; Charles A Dangler; Mark T Whary; Melanie Ihrig; Timothy C Wang
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

10.  Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer.

Authors:  A A Sakaguchi; S Miura; T Takeuchi; R Hokari; M Mizumori; H Yoshida; H Higuchi; M Mori; H Kimura; H Suzuki; H Ishii
Journal:  Free Radic Biol Med       Date:  1999-10       Impact factor: 7.376

View more
  11 in total

1.  Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice.

Authors:  Kathryn A Eaton; Lucy H Benson; Jennifer Haeger; Brian M Gray
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

2.  Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection.

Authors:  Alexander Sheh; Chung Wei Lee; Kenichi Masumura; Barry H Rickman; Takehiko Nohmi; Gerald N Wogan; James G Fox; David B Schauer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-10       Impact factor: 11.205

3.  Vitamin C supplementation does not protect L-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy.

Authors:  Chung-Wei Lee; Xiang-Dong Wang; Kuo-Liong Chien; Zhongming Ge; Barry H Rickman; Arlin B Rogers; Andrea Varro; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

4.  Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Masa Ohtani; Evelyn Kurt Jones; Timothy C Wang
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

5.  Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice.

Authors:  Marianne Quiding-Järbrink; Sukanya Raghavan; Malin Sundquist
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

6.  Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Zhongming Ge; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2008-04-25       Impact factor: 12.701

7.  DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.

Authors:  Lisiane B Meira; James M Bugni; Stephanie L Green; Chung-Wei Lee; Bo Pang; Diana Borenshtein; Barry H Rickman; Arlin B Rogers; Catherine A Moroski-Erkul; Jose L McFaline; David B Schauer; Peter C Dedon; James G Fox; Leona D Samson
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice.

Authors:  Maria Kaparakis; Anna K Walduck; Jason D Price; John S Pedersen; Nico van Rooijen; Martin J Pearse; Odilia L C Wijburg; Richard A Strugnell
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

9.  Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology.

Authors:  Laura B Lemke; Zhongming Ge; Mark T Whary; Yan Feng; Arlin B Rogers; Sureshkumar Muthupalani; James G Fox
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

10.  Gli1 deletion prevents Helicobacter-induced gastric metaplasia and expansion of myeloid cell subsets.

Authors:  Mohamad El-Zaatari; John Y Kao; Art Tessier; Longchuan Bai; Michael M Hayes; Clinton Fontaine; Kathryn A Eaton; Juanita L Merchant
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.